The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and an 8-week treatment (one capsule three times daily) reduced abdominal pain or discomfort compared with placebo (p < 0.001) in a randomized double-blind placebo-controlled study with 90 participants [30]”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [30]
In the citing paper
“Across the above studies, sex-stratified efficacy results were not reported [29,30,31,32].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 4×
“The chronic nature of IBS symptoms can adversely affect patients’ quality of life by interfering with their normal everyday life [5, 23].”
BackgroundInfluentialMedical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 1×
“IBS is a chronic troublesome condition [1] that puts both patients and the healthcare system into heavy expenses [3, 4] as a result of significant impairment in health-related quality of life [5] and work productivity [6].”
BackgroundImpact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)
Amouretti, M., Le Pen, C., Gaudin, A.-F., Bommelaer, G., Frexinos, J., Ruszniewski, P., Poynard, T., Maurel, F., Priol, G., & El Hasnaoui, A. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73160-8 · Cited by 110
Research works printed but not linked: 24
- Foxx-Orenstein A. IBS–review and what’s new. MedGenMed. 2006;8:20.
- Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: Toward a cost-effective management approach. Am J Manag Care. 2001;7:S268–S275.
- Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care. 2005;11:S17–S26.
- Hadley SK, Gaarder SM. Treatment of irritable bowel syndrome. American Family Physician. 2005;72:2501–2506.
- Kligler B, Chaudhary S. Peppermint oil. American Family Physician. 2007;75:1027–1030.
- Gobel H, Fresenius J, Heinze A, Dworschak M, Soyka D. Effectiveness of oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt. 1996;67:672–681. doi: 10.1007/s001150050040 . · DOI
- May B, Kuntz HD, Kieser M, Kohler S. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittel-Forschung. 1996;46:1149–1153.
- Sparks MJ, O’Sullivan P, Herrington AA, Morcos SK. Does peppermint oil relieve spasm during barium enema? British Journal of Radiology. 1995;68:841–843. · DOI
- Asao T, Kuwano H, Ide M, et al. Spasmolytic effect of peppermint oil in barium during double-contrast barium enema compared with Buscopan. Clinical Radiology. 2003;58:301–305. doi: 10.1016/S0009-9260(02)00532-9 . · DOI
- Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10:504–510. doi: 10.1078/094471103322331467 . · DOI · Paper page
- Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology. 1991;101:55–65. · DOI
- Hawthorn M, Ferrante J, Luchowski E, Rutledge A, Wei XY, Triggle DJ. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology & Therapeutics. 1988;2:101–118. · DOI · Paper page
- Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313. doi: 10.1136/bmj.a2313 . · DOI · Paper page
- Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with peppermint oil. BMJ. 1979;2:835–836. doi: 10.1136/bmj.2.6194.835 . · DOI
- Grigoleit HG, Grigoleit P. Peppermint oil in irritable bowel syndrome. Phytomedicine. 2005;12:601–606. doi: 10.1016/j.phymed.2004.10.005 . · DOI
- Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (mintoil) in the treatment of irritable bowel syndrome: a prospective double-blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39:530–536. doi: 10.1016/j.dld.2007.02.006 . · DOI · Paper page
- Vahedi H, Merat S, Momtahen S, et al. Clinical trial: The effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2008;27:678–684. · DOI
- Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. Journal of Gastroenterology. 1997;32:765–768. doi: 10.1007/BF02936952 . · DOI · Paper page
- Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J. 2005;11:349–357.
- Bertram S, Kurland M, Lydick E, Locke GR 3rd, Yawn BP. The patient’s perspective of irritable bowel syndrome. Journal of Family Practice. 2001;50:521–525.
- Grigoleit HG, Grigoleit P. Pharmacology and preclinical pharmacokinetics of peppermint oil. Phytomedicine. 2005;12:612–616. doi: 10.1016/j.phymed.2004.10.007 . · DOI
- Cain KC, Headstrom P, Jarrett ME, et al. Abdominal pain impacts quality of life in women with irritable bowel syndrome. American Journal of Gastroenterology. 2006;101:124–132. doi: 10.1111/j.1572-0241.2006.00404.x . · DOI
- Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH. Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities. Clin Gastroenterol Hepatol. 2009;7:73–79. doi: 10.1016/j.cgh.2008.08.011 . · DOI
- Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ. 2001;165:1339–1341.
Cited by
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Black, C. J., Yuan, Y., Selinger, C. P., Camilleri, M., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30324-3 · Cited by 171
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160
Metadata
- Authors
- Merat, S., Khalili, S., Mostajabi, P., Ghorbani, A., Ansari, R., & Malekzadeh, R.
- Venue
- Digestive Diseases and Sciences
- Published
- 2009-06-09
- Volume
- 55
- Issue
- 5
- Pages
- 1385-1390
- ISSN
- 0163-2116
- 1573-2568
- Cited by
- 122
- References
- 4
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
